Articles
View all articles-
Wockhardt bets on US, Europe for growth
Drug maker Wockhardt today said it expects the US and European markets to continue to be its mainstay in the coming years while it seeks to enhance R&D capabilities and focus on introducing new advanced therapies. #US #CorporateStrategy #Europe #Wockhardt #Pharma
-
Wockhardt receives USFDA approval for anti-ulcer drug
Drug firm Wockhardt said it has received approval from American health regulator to market Lansoprazole, a drug used in treatment of ulcers, in the US market. #NewsTracker #Wockhardt #USFDA
-
Wockhardt gets USFDA nod for anti-depressant tablets
The company has received final approval from the United States Food & Drug Administration (USFDA) for marketing bupropion hydrochloride 12-hr extended release tablets #CompanyWatch #Wockhardt #USFDA #Anti-depressent tablets
Blog posts
View all blog posts-
When will SEBI have its Rajaratnam moment?
In the backdrop of the Raj Rajaratnam conviction, Sebi's stance against Reliance Industries in the ongoing insider trading probe will be closely watched. #HowThisWorks #Raj Rajaratnam #Wockhardt Limited #Securities Appellate Tribunal #Bayer AG #Brooke Bond India
Wire
-
Indian Express
MSCI India adds Wockhardt, OIL, GSK Consumer, Apollo Hospitals
Please read our terms of use before posting comments Apollo Hospitals, Oil India, Wockhardt and GlaxoSmithKline Consumer Healthcare have been added to the MSCI (Morgan Stanley Capital International) India index. The changes will take place after the clos #Apollo Hospitals #India #GlaxoSmithKline Inc
-
Moneycontrol.com
Wockhardt, 3 other shares up on MSCI India index inclusion
New to Moneycontrol - Sign up now Username should be atleast 4 characters Keep me signed in Donât have an account? Investors are betting that the inclusion of these stocks in the MSCI Index would attract interest from global fund managers who track the i #India #Apollo Hospitals #GlaxoSmithKline Inc
-
Moneycontrol.com
IDFC Sterling Equity: Good performer; holds strong outlook
The fund focuses on medium sized companies with proven business models that will end up becoming leaders over a period of time. At the end of October 2011, the fund had the highest exposure in the portfolio to consumer non durables at 11 per cent. Financ #Nestle #India #Idea Cellular




